Detailed TOC of Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research Report 2025-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2033
Table of Content
1. Market Definition and Statistical Scope
1.1 Objective of the Study
1.2 Benign Prostatic Hyperplasia (BPH) Drugs Market Definition
1.3 Market Scope
1.3.1 Market Segmentation by Type, Downstream Industry and Marketing Channel
1.3.2 Major Geographies Covered (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
1.4 Years Considered for the Study (2019-2033)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2. Research Findings and Conclusion
3 Key Companies’ Profile
3.1 Competitive Profile
3.1.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share by Companies
3.1.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Companies
3.2 Astellas Pharma
3.2.1 Brief Introduction of Astellas Pharma
3.2.2 Astellas Pharma Sales, Growth Rate and Global Market Share from 2019-2025
3.2.3 Astellas Pharma Related Products/Service Introduction
3.2.4 Astellas Pharma Business Overview/Recent Development/Acquisitions
3.3 GlaxoSmithKline
3.3.1 Brief Introduction of GlaxoSmithKline
3.3.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2019-2025
3.3.3 GlaxoSmithKline Related Products/Service Introduction
3.3.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
3.4 Eli Lilly
3.4.1 Brief Introduction of Eli Lilly
3.4.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2019-2025
3.4.3 Eli Lilly Related Products/Service Introduction
3.4.4 Eli Lilly Business Overview/Recent Development/Acquisitions
3.5 Foresee Pharmaceuticals
3.5.1 Brief Introduction of Foresee Pharmaceuticals
3.5.2 Foresee Pharmaceuticals Sales, Growth Rate and Global Market Share from 2019-2025
3.5.3 Foresee Pharmaceuticals Related Products/Service Introduction
3.5.4 Foresee Pharmaceuticals Business Overview/Recent Development/Acquisitions
3.6 Sanofi
3.6.1 Brief Introduction of Sanofi
3.6.2 Sanofi Sales, Growth Rate and Global Market Share from 2019-2025
3.6.3 Sanofi Related Products/Service Introduction
3.6.4 Sanofi Business Overview/Recent Development/Acquisitions
3.7 Endo Pharmaceuticals
3.7.1 Brief Introduction of Endo Pharmaceuticals
3.7.2 Endo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2019-2025
3.7.3 Endo Pharmaceuticals Related Products/Service Introduction
3.7.4 Endo Pharmaceuticals Business Overview/Recent Development/Acquisitions
3.8 Bayer HealthCare
3.8.1 Brief Introduction of Bayer HealthCare
3.8.2 Bayer HealthCare Sales, Growth Rate and Global Market Share from 2019-2025
3.8.3 Bayer HealthCare Related Products/Service Introduction
3.8.4 Bayer HealthCare Business Overview/Recent Development/Acquisitions
3.9 Valeant Pharmaceuticals
3.9.1 Brief Introduction of Valeant Pharmaceuticals
3.9.2 Valeant Pharmaceuticals Sales, Growth Rate and Global Market Share from 2019-2025
3.9.3 Valeant Pharmaceuticals Related Products/Service Introduction
3.9.4 Valeant Pharmaceuticals Business Overview/Recent Development/Acquisitions
3.10 Bristol-Myers Squibb
3.10.1 Brief Introduction of Bristol-Myers Squibb
3.10.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2019-2025
3.10.3 Bristol-Myers Squibb Related Products/Service Introduction
3.10.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
3.11 ADC Therapeutics
3.11.1 Brief Introduction of ADC Therapeutics
3.11.2 ADC Therapeutics Sales, Growth Rate and Global Market Share from 2019-2025
3.11.3 ADC Therapeutics Related Products/Service Introduction
3.11.4 ADC Therapeutics Business Overview/Recent Development/Acquisitions
4. Global Benign Prostatic Hyperplasia (BPH) Drugs Market Segmented by Type
4.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue and Growth Rate by Type 2019-2025
4.2 Alpha-Blocker
4.3 Phosphodiesterase Type-5 Inhibitors
4.4 5-Alpha-Reductase Inhibitors
5 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Segmented by Downstream Industry
5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue and Growth Rate by Downstream Industry 2019-2025
5.2 Men
5.3 Women
6 Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Analysis
6.1 Value Chain Status
6.2 Upstream Raw Material Analysis
6.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
6.4 Distributors/Traders
6.5 Downstream Major Customer Analysis (by Region)
6.6 Value Chain Under Regional Conflicts
7. The Development and Dynamics of Benign Prostatic Hyperplasia (BPH) Drugs Market
7.1 Driving Factors of the Market
7.2 Factors Challenging the Market
7.3 Opportunities of the Global Benign Prostatic Hyperplasia (BPH) Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
7.4 Technology Status and Developments in the Benign Prostatic Hyperplasia (BPH) Drugs Market
7.5 Industry News
7.6 Market Investment Scenario Strategic Recommendations
7.7 COVID-19 Impact on Benign Prostatic Hyperplasia (BPH) Drugs Industry
7.7.1 Benign Prostatic Hyperplasia (BPH) Drugs Business Impact Assessment - Covid-19
7.7.2 Supply Chain Challenges
7.7.3 Market Trends and Potential Opportunities of Benign Prostatic Hyperplasia (BPH) Drugs in the COVID-19 Landscape
7.8 Industry SWOT Analysis
8 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Segmented by Geography
8.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Region 2019-2025
8.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Market Share by Region 2019-2025
9 North America
9.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2025
9.2 North America Benign Prostatic Hyperplasia (BPH) Drugs Sales Analysis from 2019-2025
9.3 North America Benign Prostatic Hyperplasia (BPH) Drugs Import and Export from 2019-2025
9.4 North America Benign Prostatic Hyperplasia (BPH) Drugs Market by Country
9.4.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2019-2025)
9.4.2 North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2019-2025)
9.4.3 United States Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
9.4.4 Canada Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10 Europe
10.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2025
10.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Analysis from 2019-2025
10.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Import and Export from 2019-2025
10.4 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market by Country
10.4.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2019-2025)
10.4.2 Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2019-2025)
10.4.3 Germany Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.4 UK Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.5 France Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.6 Italy Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.7 Spain Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.8 Russia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.9 Netherlands Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.10 Turkey Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.11 Switzerland Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
10.4.12 Sweden Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11 Asia Pacific
11.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2025
11.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Analysis from 2019-2025
11.3 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Import and Export from 2019-2025
11.4 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Market by Country
11.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2019-2025)
11.4.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2019-2025)
11.4.3 China Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.4 Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.5 South Korea Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.6 Australia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.7 India Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.8 Indonesia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.9 Philippines Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
11.4.10 Malaysia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
12 Latin America
12.1 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2025
12.2 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Sales Analysis from 2019-2025
12.3 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Import and Export from 2019-2025
12.4 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Market by Country
12.4.1 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2019-2025)
12.4.2 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2019-2025)
12.4.3 Brazil Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
12.4.4 Mexico Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
12.4.5 Argentina Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
13 Middle East & Africa
13.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2025
13.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales Analysis from 2019-2025
13.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Import and Export from 2019-2025
13.4 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market by Country
13.4.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales by Country (2019-2025)
13.4.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Country (2019-2025)
13.4.3 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
13.4.4 UAE Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
13.4.5 Egypt Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
13.4.6 South Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth (2019-2025)
14. Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast by Geography, Type, and Downstream Industry 2025-2033
14.1 Forecast of the Global Benign Prostatic Hyperplasia (BPH) Drugs Market from 2025-2033 by Region
14.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate Forecast by Type (2025-2033)
14.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate Forecast by Downstream Industry (2025-2033)
14.4 Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast Under COVID-19
15 Appendix
15.1 Methodology
15.2 Research Data Source
